These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15797960)

  • 1. Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight.
    van der Kamp HJ; Oudshoorn CG; Elvers BH; van Baarle M; Otten BJ; Wit JM; Verkerk PH
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3904-7. PubMed ID: 15797960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Measurement of 17 OH progesterone in blood in Chilean newborns: antecedents for implementing a grogram for the neonatal detection of congenital adrenal hyperplasia].
    Cattani A; Reyes ML; Azócar M; Soto J; Romeo E; Valdivia L; Poggi H; Foradori A
    Rev Med Chil; 2000 Oct; 128(10):1113-8. PubMed ID: 11349510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn screening for congenital adrenal hyperplasia in Cuba: six years of experience.
    González EC; Carvajal F; Frómeta A; Arteaga AL; Castells EM; Espinosa T; Coto R; Pérez PL; Tejeda Y; Del Río L; Segura MT; Almenares P; Robaina R; Fernández JL
    Clin Chim Acta; 2013 Jun; 421():73-8. PubMed ID: 23481450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal screening for congenital adrenal hyperplasia.
    Barra CB; Silva IN; Pezzuti IL; Januário JN
    Rev Assoc Med Bras (1992); 2012; 58(4):459-64. PubMed ID: 22930025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multicenter investigation on the impact of newborn infants' gestational age and birth weight on the level of 17α-hydroxyprogesterone].
    Zhang Q; Wang B; Chen Y; Jiang D; Chen Y
    Zhonghua Er Ke Za Zhi; 2014 Sep; 52(9):706-9. PubMed ID: 25476436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening.
    Hayashi GY; Carvalho DF; de Miranda MC; Faure C; Vallejos C; Brito VN; Rodrigues AS; Madureira G; Mendonca BB; Bachega TA
    Clin Endocrinol (Oxf); 2017 Apr; 86(4):480-487. PubMed ID: 27978607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of Serum 17α-Hydroxyprogesterone in Infants by Radioimmunoassay.
    Muñoz LN; Ochetti M; Perez G; Sobrero GM; Silvano LK; Martin SE; Testa GM; Miras MB
    Pediatr Endocrinol Rev; 2015 Jun; 12(4):366-72. PubMed ID: 26182481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum 17 alpha hydroxyprogesterone in normal full term and preterm vs sick preterm and full term newborns in a tertiary hospital.
    Chennuri VS; Mithbawkar SM; Mokal RA; Desai MP
    Indian J Pediatr; 2013 Jan; 80(1):21-5. PubMed ID: 22865354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing 17-Hydroxyprogesterone Cutoff Values for Congenital Adrenal Hyperplasia in Preterm, Low Birth Weight, and Sick Newborns.
    Yoon YA; Woo S; Kim MS; Kim B; Choi YJ
    Exp Clin Endocrinol Diabetes; 2023 Apr; 131(4):216-221. PubMed ID: 36854385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adjustment of 17-hydroxyprogesterone cut-off values for congenital adrenal hyperplasia neonatal screening by GSP according to gestational age and age at sampling.
    Jiang X; Tang F; Feng Y; Li B; Jia X; Tang C; Liu S; Huang Y
    J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1253-1258. PubMed ID: 31603856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal screening program for congenital adrenal hyperplasia: adjustments to the recall protocol.
    Gruñeiro-Papendieck L; Prieto L; Chiesa A; Bengolea S; Bossi G; Bergadá C
    Horm Res; 2001; 55(6):271-7. PubMed ID: 11805430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight-adjusted neonatal 17OH-progesterone cutoff levels improve the efficiency of newborn screening for congenital adrenal hyperplasia.
    Hayashi G; Faure C; Brondi MF; Vallejos C; Soares D; Oliveira E; Brito VN; Mendonca BB; Bachega TA
    Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):632-7. PubMed ID: 22218447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of gender, birth weight and gestational age on serum 17-hydroxyprogesterone concentration and distribution among neonates in Saudi Arabia.
    al-Nuaim AR; Abdullah MA; Stevens B; Zain M
    Indian J Pediatr; 1995; 62(5):605-9. PubMed ID: 10829930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for elevated levels of 17-hydroxyprogesterone during neonatal intensive care unit admission.
    Pauwels G; Allegaert K; Régal L; Meulemans A
    Acta Clin Belg; 2012; 67(2):88-93. PubMed ID: 22712163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia.
    Gatelais F; Berthelot J; Beringue F; Descamps P; Bonneau D; Limal JM; Coutant R
    Pediatr Res; 2004 Nov; 56(5):701-5. PubMed ID: 15371568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Gestational Age- and Birth Weight-Adjusted Cutoffs for Newborn Screening of Congenital Adrenal Hyperplasia.
    Pode-Shakked N; Blau A; Pode-Shakked B; Tiosano D; Weintrob N; Eyal O; Zung A; Levy-Khademi F; Tenenbaum-Rakover Y; Zangen D; Gillis D; Pinhas-Hamiel O; Loewenthal N; de Vries L; Landau Z; Rachmiel M; Abu-Libdeh A; Eliakim A; Strich D; Koren I; German A; Sack J; Almashanu S
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3172-3180. PubMed ID: 30865229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants.
    Nordenström A; Wedell A; Hagenfeldt L; Marcus C; Larsson A
    Pediatrics; 2001 Oct; 108(4):E68. PubMed ID: 11581476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of congenital adrenal hyperplasia by rapid determination of 17alpha-hydroxyprogesterone in dried blood spots by gas chromatography/mass spectrometry following microwave-assisted silylation.
    Deng C; Ji J; Zhang L; Zhang X
    Rapid Commun Mass Spectrom; 2005; 19(20):2974-8. PubMed ID: 16178052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Congenital adrenal hyperplasia newborn screening: Rio de Janeiro experience].
    Cardoso CB; Fonseca AA; Oliveira Mde F; Pereira BB; Guimarães MM
    Arq Bras Endocrinol Metabol; 2005 Feb; 49(1):112-9. PubMed ID: 16544042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value.
    Olgemöller B; Roscher AA; Liebl B; Fingerhut R
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5790-4. PubMed ID: 14671170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.